Standard of care (SOC): Clinical Trials

178 trials of Standard of care (SOC), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

51 completed, 44 recruiting, 38 not yet recruiting, 15 active not recruiting. 94 Not applicable, 40 Phase 2, 27 Phase 3, 13 Phase 4, 9 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable94Recruiting 28, Not yet recruiting 22, Completed 21, Active not recruiting 10, Terminated 5, Enrolling by invitation 4, Unknown 3, Withdrawn 1
Phase 240Completed 14, Not yet recruiting 8, Recruiting 7, Terminated 5, Active not recruiting 3, Withdrawn 2, Unknown 1
Phase 327Completed 11, Recruiting 6, Withdrawn 4, Not yet recruiting 3, Terminated 3
Phase 413Completed 4, Active not recruiting 2, Not yet recruiting 2, Recruiting 2, Withdrawn 2, Enrolling by invitation 1
Phase 19Recruiting 4, Not yet recruiting 2, Active not recruiting 1, Completed 1, Unknown 1

Follow Standard of care (SOC): new trials by email Literature Review of Standard of care (SOC) trials Research Report on Standard of care (SOC)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)
Rivaroxaban (Xarelto, BAY59-7939), Standard of care (SOC) - Venous Thromboembolism, Children Under 2 Years
Not yet recruitingBayer8502027-09-012026-10-02
Appendectomy as an Adjunct Procedure in Endometriosis Surgery
Appendectomy, Standard of Care (SOC) - Endometriosis
Not applicableNot yet recruitingMount Sinai Hospital, Canada2402027-04-012026-09-16
PRECISE LBCL: Precision Treatment Readiness Through Comprehensive Genomic Sequencing in 1st Line LBCL
Standard of Care (SOC) - LBCL, Comprehensive Genomic
Not yet recruitingM.D. Anderson Cancer Center602027-02-252026-09-21
Precision Modulation of Gut Microbiome Enteropathogen Colonization in Critical Illness
Synbiotic, Standard of Care (SOC) - Critical Illness
Phase 1 / Phase 2Not yet recruitingUniversity of Calgary642027-01-012026-09-10
A Randomized Controlled Trial of Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States
Doxycycline, Standard of Care (SOC) - Chlamydia Females, Gonorrhea Female
Phase 4Not yet recruitingTulane University5192027-01-012026-07-15
"Anticipant"-TIPS After a First Portal-hypertension-related Complication in Cirrhosis
TIPS, Standard of Care (SOC) - Cirrhosis
Not applicableNot yet recruitingUniversity Hospital, Toulouse2662027-01-012026-10-22
Prospective Study of ProteiOS in Lumbar Interbody Fusion (TLIF)
Allograft-derived growth factor (ProteiOS®), Standard of Care (SOC) - Degenerative Disc Disease, Spinal Stenosis Lumbar
Not applicableNot yet recruitingIsto Biologics2802026-12-012026-08-20
The Use of Cultured (Dermal) Epithelial Autografts in Severely Burned Patients
Standard of Care (SOC) - Burn Degree Second, Burn Degree Third
Not yet recruitingUniversity Children's Hospital, Zurich2362026-12-012026-05-26
DETECTRA: Remote Monitoring to Detect Rheumatoid Arthritis Flares and Treatment Response
DETECTRA, Standard of Care (SOC) - Rheumatic Disorder, Rheumatoid Arthritis (RA)
Not applicableNot yet recruitingCentre Hospitalier Universitaire Vaudois3202026-11-302026-10-05
NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
Psilocybin (drug), Standard of Care (SOC) - Psilocybin, Neuropathy
Phase 2Not yet recruitingM.D. Anderson Cancer Center832026-11-042026-10-05
SALI-10 Probiotic to Reduce Osteoradionecrosis and Dental Toxicity Following Radiation Therapy for Head and Neck Cancer
Standard of Care (SOC), Experimental drug - Head and Neck Cancer
Phase 3Not yet recruitingUniversity Health Network, Toronto2882026-11-012026-10-20
Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial
Standard of Care (SOC), Intervention sessions - COPE, Breast Cancer
Not applicableNot yet recruitingM.D. Anderson Cancer Center402026-10-302026-05-28
Primary Radiotherapy In MEtastatic Lung Cancer
Radiotherapy followed by chemotherapy, Standard of Care (SOC) - Carcinoma, Non-Small-Cell Lung (NSCLC)
Phase 3RecruitingTrans Tasman Radiation Oncology Group4202026-10-302026-10-14
Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)
Ensifentrine, Placebo, Standard of Care (SOC) - Pulmonary Disease, Chronic Obstructive
Phase 3Not yet recruitingMerck Sharp & Dohme LLC21362026-10-232026-10-15
CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock
Methylprednisone, Standard of Care (SOC) - Cardiogenic Shock, Heart Failure
Phase 2Not yet recruitingBrigham and Women's Hospital302026-10-012026-08-13
Community Support and Mobile Apps to Help Black Women Control High Blood Pressure After Pregnancy
Collaborative care, Standard of Care (SOC) - Hypertensive Disorders of Pregnancy (HDP), Hypertension, Pregnancy Induced
Not applicableNot yet recruitingUniversity of Nebraska4042026-10-012026-09-22
Efficacy of Oral Nutritional Supplement in Community-Dwelling Adults Following Acute Care
ONS, Standard of Care (SOC) - Low Muscle Strength, Malnutrition
Not applicableNot yet recruitingAbbott Nutrition3042026-10-012026-08-07
Evaluation of Safety and Efficacy of Dehydrated Human Amnion-Intermediate-Chorion Membrane (dHAICM) Allograft in Treatment of Partial Thickness Thermal Burns
Amnion-Intermediate-Chorion, Standard of Care (SOC) - Partial Thickness Burn
Phase 4WithdrawnCellution Biologics2026-10-012026-08-27
A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections
Amicidin-β topical solution - 15 mL, Amicidin-β topical solution - 50 mL, Standard of Care (SOC) - Surgical Wound Infection, Traumatic Wound Infection
Phase 1RecruitingMacro Biologics, Inc.442026-09-302026-08-17
Pix-Risk: Early Detection of Rheumatoid Arthritis Via the DETECTRA Platform
DETECTRA, Standard of Care (SOC) - Rheumatoid Arthritis (RA
Not applicableNot yet recruitingCentre Hospitalier Universitaire Vaudois1422026-09-282026-09-17

Showing 20 of 178. Sign in to see all of them.

Conditions studied

COVID-19 (14)  ·  Diabetic Foot (10)  ·  Diabetes Mellitus (5)  ·  Acute Kidney Injury (4)  ·  Sepsis (4)  ·  Surgical Wound Infection (4)  ·  Varicose Ulcer (4)  ·  Acquired Immunodeficiency Syndrome (3)  ·  Anxiety Disorders (3)  ·  Depression (3)  ·  Diabetes Mellitus, Type 2 (3)  ·  Fibrosis (3)  ·  Foot Ulcer (3)  ·  HIV Infections (3)  ·  Head and Neck Neoplasms (3)

Sponsors

Novartis Pharmaceuticals (7)  ·  Assistance Publique - Hôpitaux de Paris (5)  ·  Emory University (5)  ·  Cellution Biologics (4)  ·  M.D. Anderson Cancer Center (4)  ·  PolyPid Ltd. (3)  ·  Abbott Nutrition (2)  ·  Bayer (2)  ·  CardioRenal Systems, Inc. (2)  ·  Centre Hospitalier Universitaire Vaudois (2)  ·  EMD Serono Research & Development Institute, Inc. (2)  ·  Ethicon, Inc. (2)  ·  Irrimax Corporation (2)  ·  Janssen Research & Development, LLC (2)  ·  Johns Hopkins University (2)

Countries

United States (89)  ·  Germany (23)  ·  Italy (16)  ·  Spain (16)  ·  France (15)  ·  Australia (12)  ·  Poland (12)  ·  United Kingdom (12)  ·  Canada (11)  ·  Israel (11)  ·  Czechia (8)  ·  Switzerland (8)  ·  Denmark (7)  ·  Netherlands (7)  ·  Romania (7)

Top investigators

Shmuel Sharoni, MD (2)  ·  Aditya H Gaur, MD (1)  ·  Alan Barber, PhD (1)  ·  Alex Hall, DHSc (1)  ·  Alexandra I Halalau, MD (1)  ·  Alexandra Papaioannou, Professor of Anaesthesiology (1)  ·  Allison Matthews (1)  ·  Amy Rothberg, MD (1)  ·  Ana Rita Londral, PhD (1)

Results publications

PMID 12148093, PMID 20543206, PMID 21701326, PMID 22449295, PMID 25057935, PMID 25058504, PMID 25304302, PMID 26197368, PMID 26636489, PMID 26936623, PMID 27017161, PMID 28202770, PMID 28223475, PMID 28455343, PMID 28487318, PMID 29712625, PMID 30143033, PMID 30304509, PMID 30448118, PMID 30832717, PMID 32270297, PMID 32345658, PMID 32779730, PMID 33225960, PMID 33502773, PMID 33504262, PMID 33960843, PMID 33966447, PMID 34001215, PMID 34050768, PMID 34473343, PMID 34855613, PMID 34886993, PMID 35244208, PMID 35296307, PMID 35776441, PMID 35995638, PMID 36104613, PMID 36328157, PMID 36730762, PMID 37081534, PMID 37154020, PMID 37237315, PMID 37338154, PMID 37348035, PMID 37591523, PMID 37715999, PMID 38099161, PMID 38828958, PMID 39139188

NIH funding

2017 (4), 2025 (4), 2018 (1), 2023 (1), 5UG1MD019436-02 (1), K23MH114632 (1), K23MH131463 (1), R01CA296402 (1), R01DA041032 (1), R01DK124862 (1), R01MD015818 (1), R21AG077092 (1), R21AG083667 (1), R21AR082111 (1), R33HD110150 (1)